Nascent Biotech Stock Market Capitalization

NBIO Stock  USD 0.01  0  16.67%   
Nascent Biotech fundamentals help investors to digest information that contributes to Nascent Biotech's financial success or failures. It also enables traders to predict the movement of Nascent OTC Stock. The fundamental analysis module provides a way to measure Nascent Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nascent Biotech otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Nascent Biotech OTC Stock Market Capitalization Analysis

Nascent Biotech's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Market Cap

 = 

Shares Outstanding

X

Share Price

More About Market Capitalization | All Equity Analysis

Current Nascent Biotech Market Capitalization

    
  10.76 M  
Most of Nascent Biotech's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nascent Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Competition

Based on the recorded statements, the market capitalization of Nascent Biotech is about 10.76 M. This is 99.92% lower than that of the Healthcare sector and 99.77% lower than that of the Biotechnology industry. The market capitalization for all United States stocks is 99.94% higher than that of the company.

Nascent Market Capitalization Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nascent Biotech's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Nascent Biotech could also be used in its relative valuation, which is a method of valuing Nascent Biotech by comparing valuation metrics of similar companies.
Nascent Biotech is currently under evaluation in market capitalization category among its peers.

Nascent Fundamentals

About Nascent Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nascent Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nascent Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nascent Biotech based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Nascent Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nascent Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nascent Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving together with Nascent OTC Stock

  0.67NVO Novo Nordisk ASPairCorr
  0.66NONOF Novo Nordisk ASPairCorr
  0.8CSLLY CSLPairCorr

Moving against Nascent OTC Stock

  0.84GE GE AerospacePairCorr
  0.7NSFDF NXT Energy SolutionsPairCorr
  0.63IBM International BusinessPairCorr
  0.49COST Costco Wholesale Corp Sell-off TrendPairCorr
  0.47KO Coca Cola Aggressive PushPairCorr
The ability to find closely correlated positions to Nascent Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nascent Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nascent Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nascent Biotech to buy it.
The correlation of Nascent Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nascent Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nascent Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nascent Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Nascent OTC Stock

Nascent Biotech financial ratios help investors to determine whether Nascent OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nascent with respect to the benefits of owning Nascent Biotech security.